Clinical trial
Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines
NCT02159482 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines
- Lead sponsor
- Duke University
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2005
- Completion date
- May 31, 2008
- Enrollment
- 11 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cancer